PD-1 and PD | 合法醫療器材資訊網

Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer ... Read More

In 2016, the FDA approved atezolizumab for urothelial carcinoma and non-small cell lung cancer. Avelumab (Bavencio) is a fully human IgG1 antibody developed by ... Read More

阿替利珠單抗（Atezolizumab，商品名Tecentriq，中文商品名泰聖奇）是一種用於治療治療尿路上皮癌、非小細胞肺癌（NSCLC）、三陰性乳腺癌、小細胞肺癌和肝細胞癌的IgG1 ... Read More

Learn about TECENTRIQ® (atezolizumab), a cancer Immunotherapy treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC), Extensive-Stage Small Cell Lung ... Read More

2021年7月2日 — Atezolizumab (Tecentriq). From HemOnc.org - A Hematology Oncology Wiki. Jump to: navigation, search. Share ... Read More

Atezolizumab es un medicamento que pertenece a la familia de los anticuerpos monoclonales. Se ha sintetizado mediante técnicas de ingeniería genética y va ... Read More

L'atézolizumab est un anticorps monoclonal humanisé contre le PD-L1. Il permet d'activer la migration, la prolifération et la production de cytokines par ... Read More

Atezolizumab (trade name Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 ... Read More

2021年4月1日 — Tecentriq (atezolizumab) — Roche. Pivotal Phase III study shows Roche's Tecentriq helped ... [2]: https://en.wikipedia.org/wiki/Atezolizumab Read More